A Website For Doctors and Health Professionals

LEAD -- THE #1 ENVIRONMENTAL
HAZARD TO MANY CHILDREN

At high doses, lead has long been known to cause severe health problems -- muscle and abdominal pain, brain disease, paralysis and even death. In recent years, however, we have grown to appreciate the devastating effects of even low-level lead exposures early in life.

Although leaded paint and leaded gasoline have been phased out, lead remains in old paint, household dust, soil, pipe solder (from which it leaches into water) and some ceramics. Basic research financed by the National Institute of Environmental Health Sciences has shown the adverse effects on children's IQ and physical development of lead levels previously considered safe. Based on these and other findings, public health officials declared lead the #1 environmental hazard to American children and the federal Centers for Disease Control and Prevention lowered what is considered to be "acceptable" blood lead levels.

Research by NIEHS grantees has helped to show the sources of lead in the environment and to design public health prevention efforts, as well as treatments to remove lead from affected children, a process called chelation.

To help improve this treatment, NIEHS supported the study of dimercaptosuccinic acid (DMSA). Known generically as Succimer and trade-named Chemet, it has the advantage over previously used intravenous therapies that it can be given by mouth, without hospitalization.

Succimer is approved by the Food and Drug Administration for use at lead levels above 45 micrograms per deciliter of blood. However, a treatment may be needed for children with blood lead levels of 10-25 micrograms because there are effects possible at even these low levels.

• To meet this need, NIEHS is conducting a clinical trial to test Succimer in children whose blood lead concentrations are within this lower range. Inner-city hospitals are participating in this trial in Cincinnati, Ohio; Newark, N.J., Philadelphia, Pa., and Baltimore, Md. The National Institutes of Health's Office of Research on Minority Health also is helping to support this trial. The aim is to see if oral chelation reduces or prevents lead induced developmental problems. Eight hundred youngsters are now being followed.

Additionally:

• Recent studies supported by NIEHS suggest that a young person's lead burden is not only linked to lower IQ and lower high school graduation rates but to increased delinquency.

• Preliminary data from two other NIEHS studies indicate that lead stored in young women's bones during childhood can be returned to the blood during times of calcium need, such as pregnancy, and expose their fetuses.

NIEHS continues to perform and support research on lead's effects. The research is important because of the prevalence of lead in the environment and because lead may represent a model of how other environmental hazards can hurt the fetus or developing child and adolescent, even at relatively low levels of exposure.

NIEHS Fact Sheet #8 -- LEAD 3/97

Our publications are not copyrighted and may be reproduced without permission. However, we do ask that credit be given to the National Institute of Environmental Health Sciences, National Institutes of Health. http://www.niehs.nih.gov

We welcome your questions be they by phone or email.

Your health is a vitally important and we are happy to answer your questions about oral chelation and its advantages for you.

Please don't hesitate to contact us at

Extended Health
info@extendedhealth.com
1-800-300-6712
Monday to Friday 9:00AM to 5:00 PM Pacific Standard Time
Fax 925-988-8013

2175 N. California Blvd. Suite 150
Walnut Creek, CA 94596
USA

 

Pharmaceutical Quality, FDA approved manufacturing plant and procedures

 

Back to the top

Links

Privacy

Extended Health takes your personal privacy seriously. Because we value our customer relationship with you, we do not sell customer information or share it with organizations.

Thank you for choosing Extended Health. We appreciate your business.

______________________________________________________________________
Disclaimer:

All information on this site is provided for informational purposes only! By no means is any information presented herein intended to substitute for the advice provided to you by your own physician or health care provider. You should not use any information contained in our site to self-diagnose or personally treat any medical condition or disease or prescribe any medication. If you have or suspect you have a medical condition you are urged to contact your personal health care provider immediately. All health supplements or products purchased in this site contain clearly labeled product packaging, which must be read to ensure proper use. All information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. It has not been conclusively established that oral chelation is an effective treatment or cure for any disease or condition or that it actually prevents or mitigates such harm. However, Extended Health, Inc. believes that the use of its products is a responsible precautionary stop for those people who are informed and concerned about such matters.

The National Institute of Health recently began a five-year double blind study on the effects of intravenous chelation. Since qualified doctors have offered their patients chelation treatments for over thirty years, we all look forward to these results. Extended Health has a doctor's label featuring the exact oral chelation formula that we sell directly to the public. We've sold this to doctors for over four years!

If any customer is not satisfied with Extended Health's Oral Chelation Formula we will refund the purchase price upon return of the unused product and proof of purchase to Extended Health, Inc.